Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect

P. Escalante, T. Peikert, V. P. Van Keulen, C. L. Erskine, M. D. Behrens, L. A. Schenck, A. H. Limper (Rochester, United States Of America)

Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Session: Tuberculosis: from diagnosis to therapy and prevention
Session type: Poster Discussion
Number: 3064
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Escalante, T. Peikert, V. P. Van Keulen, C. L. Erskine, M. D. Behrens, L. A. Schenck, A. H. Limper (Rochester, United States Of America). Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect. Eur Respir J 2014; 44: Suppl. 58, 3064

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Verification of pulmonary tuberculosis in HIV-infected patients with low CD4
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014


Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Association of serum cytokines with pulmonary tuberculosis treatment outcomes
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016



Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value?
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016


CD27 expression as a new tool to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015


Differential characteristics of tuberculosis among immigrants
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013


Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016


Acute phase reaction in pulmonary tuberculosis during treatment
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015